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Essential hypertension also known as idiopathic 
hypertension or primary Hypertetion is the form of 
Hypertetion which has no identifiable cause it is the 
most common type of hypertension affecting 95% of 
the hypertensive patients.[1] Cardiovascular diseases 
caused 2.3 million deaths in India in the year 1990; 
this is projected to double by the year 2020. 
Hypertension is directly responsible for 57% of all 
stroke deaths and 24% of all coronary heart disease 
deaths in India. There is a strong correlation between 
changing lifestyle factors and increase in hypertension 
in India.[2]  Hypertension is called a silent killer 
because it rarely causes symptoms before it damages 
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the heart, kidneys or brain.[3] It is estimated that 600 
million people are affected worldwide with 
hypertension. By the year 2025, approximately 1 in 3 
adults aged over 20 years, totally 1.56 billion people 
worldwide, will have hypertension.[4]  
The disease Essential Hypertension  is neither 
denoted in Samhita nor in any Samgraha Granthas, 
but it is stated that every disease cannot be given 
nomenclature.[6]  The term “hypertension” was coined 
after the invention of sphygmomanometer, however 
before that about its existence, one can trace the 
pathway on the tract of symptomatology. Many works 
have been carried out on hypertension to evaluate 
the perfect diagnosis and mode of treatment on the 
basis of Ayurvedic principles, different nomenclatures 
also have been adopted by Ayurvedic scholars like 
Shonitamada, Raktagata Vyana Vayu, Shiragatavata, 
Rakta Chapa, Raktavrita Vata, Raktavriddhi, 
Raktavata etc. the main pathogenesis occurs in Rasa 
and Raktadhatu in blood vessels. It is Vata Pitta 
Pradhana Tridoshaja disorder.[7] 
CASE REPORT 
A male patient name Yogesh age of 42 years k/c/o 
hypertension since 1 year (not under regular 
medication) was said to be healthy before 10 years. 
A B S T R A C T  
Hypertension is called a silent killer because it rarely causes symptoms before it damages the heart, 
kidneys or brain. It is estimated that 600 million people are affected worldwide with hypertension. By 
the year 2025, approximately 1 in 3 adults aged over 20 years, totally 1.56 billion people worldwide, 
will have hypertension. Many works have been carried out on hypertension to evaluate the perfect 
diagnosis and mode of treatment on the basis of Ayurvedic principles, different nomenclatures also 
have been adopted by Ayurvedic scholars like Shonitamada, Raktagata Vyana Vayu, Shiragatavata, 
Rakta Chapa, Raktavrita Vata, Raktavriddhi, Raktavata etc. 
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Gradually he started to get pain in temporal region 
on/off through day pain was in dull ache in nature 
aggravated by stress and exposed to cold and relived 
by taking rest and tablets. He was also having 
complaint of pain in calf region it was not radiating 
type and dull pain aggravated by doing work and 
relived by taking rest and oil massage. 1 year back he 
felt severe weakness, heaviness in head and giddiness 
on/off  and consulted Columbia Hospital, Bengaluru, 
where he underwent vitals monitoring, ECG and blood 
investigations and blood pressure found to be 
150/90mmhg and there by physician prescribed 
antihypertensive and antihyperlipidemic drugs  for 
3months (patient took only antihyperlipidemic for 3 
months) and since 3 months patient feeling of 
heaviness in body  and it increased generalized 
weakness since 15 days, with all these complaints 
patient visited SKAMCH&RC, Bengaluru and got 
admitted on 28/11/2019 (OPD no G816 and IPD no 
5994/19) 
GENERAL EXAMINATION 
Pulse: 96/min, Respiratory rate: 22/min, Blood 
pressure: 150/96 mm of Hg, Temperature: 98.6°F, 
General condition: fair, Pallor: Absent, Icterus: Absent, 
Lymphadenopathy: Absent, Cyanosis: Absent, 
Clubbing: absent, edema: absent. 
SYSTEMIC EXAMINATION 
Central Nervous System: Higher mental functions 
normal, Patient is well conscious and oriented to time 
place person is intact, Cranial nerve examination 
intact, Both sensory and motor function examination 
intact, Superficial and deep tendon reflexes normal.       
Respiratory System: No surgical scars rashes redness 
seen and Bilateral symmetrically chest movements on 
breathing on inspection, no local tenderness and 
palpable mass felt on palpation, Resonant note heard 
on percussion, no abnormal bronchovesicular sounds 
heard on auscultation. 
Gastrointestinal Tract: No any surgical scar marks and 
scaphoid shape seen On inspection , No palpable mass 
and tenderness felt on palpation , Fluid thrill and 
shifting dullness test negative On percussion Normal 
bowel sounds heard 8/min On auscultation 
Cardiovascular System: Chest shape – normal, 
Position of trachea – central, Apex beat – not visible 
dilated and engorged veins, no surgical or any scars 
seen on inspection, Apex beat – palpable. Trachea – 
not deviated on palpation.Cardiac dullness heard on 
percussion.S1 S2 head no added sounds or murmurs 
heard on auscultation 










168/100 mmhg 168/100 mmhg 
30/11/2019 
10:40am 
162/96 mmhg 162/96 mmhg 
Dashavidha Pariksha (Ten important aspects for 
examination) 
▪ Prakriti - Pitta (Sadhak), Vata (Prana Vyana) 
▪ Vikriti - Pitta 
Hetu - Vatapittaprakopakaraahara Vihara 
Dosha - Vata Pitta Pradhanatridosha 
Dushya - Raktameda 
Prakruti - Pitta Vata 
Desha - Sadharana 
Kaala - Hemantarutu 
Bala - Madhyama 
▪ Sara - Pravara 
▪ Samhanan - Pravara 
▪ Satmya - Sarva Rasa 
▪ Satwa - Avara 
▪ Praman - Pravara 
▪ Ahara Shakti - Pravara 
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▪ Vyayam Shakti - Madyama 
▪ Vaya - Madhyama 
Ashtavidha Pareeksha (Eight important aspects for 
examination) 
▪ Nadi - Mandukagati  
▪ Mala - Prakruta  
▪ Mutra - Prakruta  
▪ Jivha - Nirlipta Jihva 
▪ Shabda - Prakruta  
▪ Sparsha - Anushna 
▪ Drik - Vikruta (laser treatment done for left eye 
for vision correction ) 
▪ Akruti - Prakruta 
Probable diagnosis: Shiroabhitapa (Primary or 
Essential Hypertension) 
Intervention 
Sarvangatakradhara with Musta, Amalaki and Takra 
for 8 days. 
Sarvanga Abhyanga with Yashtimadhu Taila followed 
by Mrudubasphasweda for 8 days 
Snehapanaarohanakrama according Samyak Snigdha 
Laxana 
On 9th day Snehapana with Mahatiktaka Ghrita 15ml 
+ Sukumara Ghrita 15ml + 1 pinch of Saindava 
Lavana. 
On 10th day Snehapana with Mahatiktaka Ghrita 30ml 
+ Sukumara Ghrita 30ml + 1 pinch of Saindava Lavana 
On 11th day Snehapana with Mahatiktaka Ghrita 
120ml + Sukumara Ghrita 120ml + 1 pinch of Saindava 
Lavana 
On 12th, 13th, 14th day Vishrama Kala 
On 15th day Virechana according to Koshta and 
Agniavastha dosage given with Trivritlehya 70gms 
with 100ml of Triphala Kashaya at Sleshmagata Kala 
after Abhyanga and Sweda. 
Laingiki, Manaki Lakshana were observed 
Kaphapittante accordingly. 
Vegaki Lakshanas  - Total number of  Virechana Vegas  
observed - 25 
No Chardivega observed  




Takra - 125 tola (125*12=1500ml),  
Amalaki Churna - 2 Karsha (2 *12=24)    
Musta Churna - 2 Karsha (2 *12=24) prasruta,  
Jala - 16 Kudav ( 16*192=3072ml) 
The powder of Amalaki and Musta Churna, water 
should be taken in the mentioned proportions. They 
should be heated on moderate fire on the stove until 
½  of water remains (i.e. until 8 kudava = 1536ml) The 
contents should be filtered to this equal quantity of 
takra - 125tola (1500 ml) is added the medicine for 
Takra Dhara is ready for use.  
Procedure 
Poorva Karma  
Preparation of Patient (Atura Pariksha) 
A morning hour after the evacuation of the bowel and 
bladder as well as brushing the teeth, is the ideal time 
for the Parisheka Sweda.   
The patient is advised to do some warming up 
exercise.  
The therapist should chant the Swasthivachana or 
prayer before starting the procedure.  
The patient is advised to sit on the droni with 
minimum clothing.  If the condition is needed 
Abhyanga should be done prior to Parisheka.   
Pradhana Karma 
The Parisheka should be done by four therapists, two 
each perform the procedure on either side of the 
patient and other two therapists for collecting Takra. 
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Procedure review  
Pouring of the medicine should be continuous, free 
flowing, uniform and the height of the tip of Gindi and 
surface of patient’s body should be 9 inches (12 
angula) throughout the procedure. The direction of 
pouring should be from above downwards in 
extremities and below upwards in trunk and it should 
cover the whole surface of the body.   
Parisheka should be done to Shiras initially at frontal 
side (in the form of Shirodhara) followed by whole 
body in seven positions as follows;  
Sitting position with fully extended lower limbs.   
Lying down on the back with fully extended limbs.   
Lying down on the left lateral position with right arm 
fully extended and kept on the right side.  Lying down 
on the abdomen with fully extended limbs.    
Lying down on the right lateral position with left arm 
fully extended and kept on left side.  
Lying down on the back with fully extended limbs.  
Sitting position with fully extended lower limbs.   
Total duration of this procedure should be 36 to 72 
minutes (11/2 to 3 Ghatika) or till the appearance of 
sweating to the patient. 
Every day the Takra was prepared fresh for this 
procedure.  
Paschat Karma 
After performing Parisheka, the patient is advised to 
take rest for about 15 minutes.  
Person should take hot water bath only when 
sweating stops completely.   
Food should be Laghupaki and it should be served hot 
and fresh.  
Abhishyandhiahara like Dadhi should be avoided. 
Avoidance of Ashta Maha Doshakara Bhava 
Sweda Karma rectifies the function of 
Medadhatwagni and Bhutagni and fastens the Paka 
Karma which causes Srotomukhasodhana and profuse 
Sweda production. That cause the displacement of 
exudates hence relieve pain, relaxes muscular spasm. 
By Swedana due to arterial dilatation the part gets 
more circulation. So acts as Stambhaghna, 
Gourabaghna, Sitaghna and also Prabha Varna Kara. 
So Sweda Karma maintain the thermo regulation 
system of the body by maintaining equilibrium 
between core temperature (temp. inside the body) 
and shell temperature (skin temp.). 
Virechana 
Poorva Karma 
Deepana Pachana as per the condition of Agni, 
Deepana and Pachana was done for 2-3 days by Tab. 
Chitrakadivati in a dose of 2 tablets 3 times in a day 
before food for 3 days.  
Snehana according to Koshtha and Agni, 
Sukumaraghrita and Mahatiktakaghrita was given for 
Snehapana in an increasing dose of 30-60 ml/day for a 
period of 3 days.  
Yastimadhu Bahya Sweda, Bahya Snehana and 
Sarvanga Mridu Bashpa Sweda were done twice for 3 
days after achieving Samyak Sneha Lakshana.  
Pradhana Karma  
Virechana Karma with Trivritlehya 70 gm with 100ml 
Triphala Kashaya given 
Pashchat Karma  
Advised Samsarjana Krama based on Vegikimaana  of 
Virechana. 
Drug  
SN Medicine Reference 
1. Moorchita 
Tila Taila 








Sahastra Yogam Ghrita Prakarana 
Atanga Hridaya Sutrasthana 15/9-10 
4. Trivrit Lehya Atanga Hridaya Kalpasthana 2/9 
5. Triphala 
Kashaya 
Bhaishajya Ratnavali Shotanrogadhikara 10 
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Samprapti[20] 
Flow Chart 1: Hypothetical Samprapti flow chart of hypertension. 
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Probable Mode of action of Takradhara[21] [22] 
Takradhara have a balancing effect on the deepest 
recesses of our brains, stimulating the  endocrine 
system, the pituitary and pineal glands (for 
hormonalimbalances) and pleasure neurotransmitters 
(for depression or emotional insecurity). It is also said 
to enhance blood circulation to the brain, improving 
clarity and releasing deeply trapped Aama, or toxins.  
If the Dhara is dropped on the forehead nearer to the 
eyebrows, it provide more relief to the patients. 
Sushruta has mentioned SthapaniMarma between the 
two eyebrows. It is Vishalyaghana type of the Sira 
Marma. The hypotensive effect of Takradhara proved 
by this study seems to be mediated through this 
Sthapani or KurchaMarma. Being a Sira Marma it 
might have some reflex action on the baroreceptors 
which are disturbed in hypertension and may be held 
responsible for constriction of the arterioles leading 
to rise in blood pressure. Takradhara reduced both 
systolic and diastolic pressure in a more pronounced 
way. 
The mode of action of takradhara is attributed to the 
therapeutic effects of the medicine, takra procedural 
effect of the process like pressure, rhythmic 
streaming.local application of heat ,treatment timing 
,the rhythmic streaming, pressure of the medicine and 
temperature causes vasodilatation and helps the 
medicine to penetrate through the follicular pores to 
the follicles and then to the dermis via the sebaceous 
glands.The permeability of the cell of the sebaceous 
glands is greater than that of granular layer of 
epidermis. The procedure helps in oxygen 
consumption, normalizing blood pressure, brain 
cortisones and adrenalin levels, muscle tension and 
probably an increase in alpha brain waves. The space 
between the two eye brows is the seat of pituitary 
and pineal gland Pitutatry gland is one of the main 
glands of the endocrine system and exhibits its action 
on other organs.  
When Vitiated Vayu enter in Rakta dhatu (blood 
element) it cause. The blood and Pitta have an 
inseparable relationship as Pitta resides in the blood. 
When the Pitta gets vitiated, it can vitiate the Rakta 
too and vice versa. Takradhara pacify Rakta and Pitta 
dosha’susna (hot) and tisnaguna with its coolant 
property.  
Chakras stimulation effect Takradhara may stimulate 
Chakra thereby improving the functions of mind 
which is vitiated in Stress as it is the place of subtle 
mind. Structures like Pituitary gland, pineal body, 
subcortic structures of mid brain are related with 
mental functions like anger, grief, pain, fear, memory 
and other higher intellectual functions .Dhara acts at 
this level improving their functions.  
Effect on Endocrine system We all know that The 
hypothalamus is the main regulator of endocrine 
system so effect of Takradhara on hormone secretion 
can also be postulated considering the effect on 
hypothalamus. The hypothalamic Neurons which 
secrete the regulatory hormones are themselves 
under the control of specialized Monoaminergic, 
neurotransmitter neurons which arise in the mid 
brain. These are releases Dopamine, nor-adrenaline 
and Serotonin. In turn, these mid brain nuclei are 
under the control of visceral brain and are responsive 
to stress and emotional disturbances. 
Probable mode of action of Virechana[23] 
The Virechana Karma clears the Margavarodha 
(obstruction), eliminates the morbid Doshas from 
Rakta, and regulates the activity and movement of 
Vata. Thus, it controls the high BP. According to the 
modern point of view, during Virechana process, the 
inflammation of intestinal mucosa leads to hyperemia 
and exudation resulting into increased passage of 
protein‑rich fluids through vessel walls to intestinal 
lumen. Increase in fluid volume also results in the 
dilution of toxic material. Evacuation of the fluid from 
Rasa Rakta by Virechana is the direct process that 
leads to decrease in fluid volume.  
Few studies correlated acetylcholine with Vata, 
catecholamine with Pitta, and histamine with Kapha. 
It has been observed that after Virechana, there is 
reduction in the plasma catecholamine contents of 
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the patients to a statistically significant level. In that 
study, it has been observed that the effect of 
Virechana on neurohumors was highly significant.[17] 
Virechana evacuates all morbid Doshas from all micro 
to macro Dhatu channels and regulates Vata, thus 
decreasing all symptoms of Vata, Pitta, and Kapha on 
Srotas level. 
CONCLUSION 
As explained above excessive salt intake, genetic 
factor, alcohol, stress etc. might be cause and the 
patient got complaints of shiroruk, tamodharashana, 
tandra, gurugatrata, dourbalya having similarity with 
symptoms of essential hypertension. As it is primary 
hypertention pathology is known. blood pressure was 
found to be 150/96 mmhg in both supine and sitting 
position by examining blood pressure in both upper 
limbs continuously 3 day and there  not specific cause 
related to cardiac or other system so patient 
diagnosed as essential hypertention. Lakshanas seen 
at the time of admission like shirogourava, 
brhamashirashoola dourbalyata etc.  were 
significantly reduced at the time of discharge with 
blood pressure in  normal range 130/80. In modern 
science Many antihypertensive drugs have their 
primary action on systemic vascular resistance. Some 
of these drugs produce vasodilation by interfering 
with sympathetic adrenergic vascular tone 
(sympatholytics) or by blocking the formation of 
angiotensin II or its vascular receptors. In Ayurveda 
Takradhara acts on hypothalamus mid brain limbic 
system and both on sympathetic and parasympathetic 
system. Virechana acts on acetylcholine, 
catecholamine, histamine. On the other side 
Takradhara Virechana Karma acts on Pitta and 
Vatadosha and Bahya and Abhyntara Snehana acts on 
Vatadosha as disease concern Shiroabhitapa is Vata 
Pitta Pradhna Tridoshajavyadi. So proposed line of 
treatment having significant role in reducing blood 
pressure as its result patient got significant relief from 
symptoms with normal blood pressure. On the basis 
of our clinical observation, it is concluded that the 
trialed intervention is safe and effective without 
producing adverse effects in the management of 
Essential hypertension due to their 
pharmacodynamics action. Takradhara, Virechana 
and bed rest reduces stress and strain and also acted 
on Vata-Pittahara along with unexplained effect on 
the body i.e. Indriyaprassannata with Srotoshudhhi 
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